Pitfalls in the diagnosis of autoantibodies associated with paraneoplastic neurologic disease.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 8649581.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
We studied the sera of 15 patients with Sjögren's syndrome using the Western blot technique for the presence of anti-Ro and anti-Hu (type 1 antineuronal nuclear autoantibody [ANNA-1]). All sera reacted with Ro-52 protein. Two of the Sjögren sera reacted with 38-kd bands on Western blots of rat cerebellar homogenate, resembling anti-Hu immunoreactivity. However, when reacted with purified human Purkinje cells or purified recombinant HuD protein, none of the sera immunoreacted with the Hu antigens. We recommend the use of either a recombinant Hu protein or the combination of immunohistochemistry and Western blot of purified human neuronal preparations to identify paraneoplastic antibodies. This approach will prevent the unnecessary workup for suspected lung cancer.
Medical subject headings
- Autoantibodies
- Autoantigens
- Autoimmune Diseases
- Cerebellum
- Lung Neoplasms
- Nerve Tissue Proteins
- Paraneoplastic Syndromes
- RNA, Small Cytoplasmic
- RNA-Binding Proteins
- Ribonucleoproteins
- Sensation Disorders
- Sjogren's Syndrome